Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)
Clinical trial NCT04541173 · TERMINATED
Trial details
- NCT number
- NCT04541173
- Sponsor
- Aiwu Ruth He, MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2023-06-18
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.